Cancer drug marketing doesn't reduce mortality
2024-04-22 21:13:16.466336+02 by Dan Lyke 0 comments
...We find that prescribing of the associated drug increases 4\% in the twelve months after a payment is received, with the increase beginning sharply in the month of payment and fading out within a year. A marketing payment also leads physicians to begin treating cancer patients with lower expected mortality. While payments result in greater expenditure on cancer drugs, there are no associated improvements in patient mortality.